We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+26.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$6.18B
AUM Growth
+$2.27B
Cap. Flow
+$1.4B
Cap. Flow %
22.72%
Top 10 Hldgs %
7.21%
Holding
2,699
New
906
Increased
683
Reduced
582
Closed
520

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$40.9M
2
PFE icon
Pfizer
PFE
+$37.8M
3
HON icon
Honeywell
HON
+$33.2M
4
JPM icon
JPMorgan Chase
JPM
+$32.4M
5
CME icon
CME Group
CME
+$31.7M

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$33.3M
2
PYPL icon
PayPal
PYPL
+$33.1M
3
AMZN icon
Amazon
AMZN
+$32.1M
4
PPG icon
PPG Industries
PPG
+$27.6M
5
ADSK icon
Autodesk
ADSK
+$26.4M

Sector Composition

Rank Sector Weight
1 Technology 15.23%
2 Consumer Discretionary 14.63%
3 Healthcare 13.67%
4 Financials 11.93%
5 Industrials 11.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBI icon
1351
MBIA
MBI
$288M
$467K 0.01%
+64,429
New +$468K
IART icon
1352
Integra LifeSciences
IART
$1.54B
$465K 0.01%
+9,899
New +$487K
WAFD icon
1353
WaFd
WAFD
$2.72B
$465K 0.01%
+17,307
New +$446K
PENG
1354
Penguin Solutions Inc
PENG
$2.76B
$465K 0.01%
+34,226
New +$436K
ALNY icon
1355
Alnylam Pharmaceuticals
ALNY
$36.3B
$464K 0.01%
3,132
-8,604
-73% -$1.16M
LIND icon
1356
Lindblad Expeditions
LIND
$1.76B
$464K 0.01%
60,070
+46,745
+351% +$323K
ONTO icon
1357
Onto Innovation
ONTO
$13.6B
$463K 0.01%
+13,592
New +$442K
STBA icon
1358
S&T Bancorp
STBA
$1.86B
$463K 0.01%
+19,758
New +$478K
TRN icon
1359
Trinity Industries
TRN
$2.97B
$458K 0.01%
21,499
-8,528
-28% -$164K
CLVT icon
1360
Clarivate
CLVT
$1.3B
$457K 0.01%
+20,470
New +$462K
FMC icon
1361
FMC
FMC
$1.42B
$455K 0.01%
+4,563
New +$421K
MATX icon
1362
Matsons
MATX
$6.37B
$454K 0.01%
+15,590
New +$448K
GRTS
1363
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$454K 0.01%
68,410
+39,652
+138% +$267K
DENN
1364
DELISTED
Denny's
DENN
$453K 0.01%
+44,833
New +$460K
PLSE icon
1365
Pulse Biosciences
PLSE
$2.09B
$453K 0.01%
+43,278
New +$390K
NOK icon
1366
Nokia
NOK
$50.8B
$452K 0.01%
102,636
+29,571
+40% +$112K
RBA icon
1367
RB Global
RBA
$20.8B
$452K 0.01%
11,076
-12,106
-52% -$495K
ITI
1368
DELISTED
Iteris, Inc.
ITI
$451K 0.01%
94,751
+567
+0.6% +$2.37K
MPAA icon
1369
Motorcar Parts of America
MPAA
$261M
$450K 0.01%
+25,493
New +$360K
PLUS icon
1370
ePlus
PLUS
$2.33B
$450K 0.01%
12,728
-19,706
-61% -$673K
EXPO icon
1371
Exponent
EXPO
$2.98B
$449K 0.01%
5,554
+389
+8% +$28K
RPD icon
1372
Rapid7
RPD
$634M
$444K 0.01%
+8,698
New +$405K
HLIO icon
1373
Helios Technologies
HLIO
$2.64B
$443K 0.01%
+11,898
New +$406K
BCEL
1374
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$443K 0.01%
+20,810
New +$368K
LNW
1375
DELISTED
Light & Wonder
LNW
$442K 0.01%
28,561
+5,519
+24% +$72.1K

Similar funds

Squarepoint's Q2 2020 Portfolio in Review

As of Q2 2020, Squarepoint held 2,699 positions worth $6.18B, up 58% from $3.91B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Squarepoint deployed $1.4B of net new capital in Q2 2020, opening 906 new positions and adding to 683 existing holdings. Its largest new stake was Citigroup: 482,502 shares worth $24.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was PayPal, an estimated $33.1M trimmed.

  • Squarepoint's largest Q2 2020 buy was Citigroup: 482,502 shares worth $24.7M.
  • Squarepoint added most to Biogen in Q2 2020, an estimated $40.9M increase.
  • Squarepoint's biggest Q2 2020 reduction was PayPal, cutting an estimated $33.1M.
  • Squarepoint fully exited Exelon in Q2 2020, selling an estimated $33.3M.
  • Squarepoint's ten largest holdings make up 7.2% of its $6.18B portfolio in Q2 2020.
  • Squarepoint opened 906 new positions and closed 520 in Q2 2020.
  • Squarepoint's portfolio value rose 58% quarter-over-quarter to $6.18B.

Based on Squarepoint's 13F filing for Q2 2020, filed 14 Aug 2020.